Drug General Information
Drug ID
D04ETV
Former ID
DIB000407
Drug Name
Nemonaxacin
Indication Methicillin-resistant staphylococcus aureus infection [ICD10:B95.62] Phase 3 [524857]
Company
Warner Chilcott plc
Target and Pathway
Target(s) Topoisomerase IV Target Info Modulator
References
Ref 524857ClinicalTrials.gov (NCT02205112) A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.